Public Release: 

Researchers narrow in on genetic factors that cause preterm birth

Study of European mothers identifies gene involved in steroid signaling as factor in early birth



IMAGE: Researchers narrow in on genetic factors that cause preterm birth. view more 

Credit: Laikipia, Pixabay, (CC0 Creative Commons)

Mutations in a gene involved in steroid signaling likely contribute to preterm birth, report Johanna Huusko of the University of Oulu and Cincinnati Children's Hospital Medical Center and colleagues, in a study of European women who had experienced at least one early delivery. The researchers report their findings July 12th in PLOS Genetics.

Preterm birth, which occurs before 37 weeks, is a leading cause of infant mortality and can cause developmental delays and problems with learning, vision and hearing that persist into adulthood. Behavioral factors, such as smoking, drinking and stress can all contribute to early labor, but despite numerous studies, the genetic factors that increase the odds of preterm birth are poorly understood. Huusko and her colleagues attempted to identify potentially damaging genetic variants in mothers from families with a history of unexplained preterm births. They sequenced all of the DNA that holds instructions for making proteins from 17 Finnish mothers and 93 pairs of Danish sisters and discovered that a few women from both groups carried mutations in a gene called HSPA1L. This gene codes for a "molecular chaperone" that helps new proteins to fold correctly, and prevents proteins from clumping together inside cells. Additional experiments in cell cultures showed these mutations likely interfere with proper functioning of the chaperone within the cells that line the uterus, as they prepare for and maintain a pregnancy.

Mutations in HSPA1L are rare, even in this population of mothers with a history of preterm birth. But the discovery can help point researchers toward related signaling pathways, whose disruption may be contributing to early births. HSPA1L is involved in a steroid signaling pathway where it helps tamp down inflammation and suppress the immune system. Overall, the findings suggest that future studies should investigate steroid signaling as a possible factor in whether a woman delivers early, or carries a baby to term.

The authors add: "Defining genetic contributors to preterm birth risk has proven challenging for many reasons - heterogeneous causes that increase risk and the added complexity of two interacting genomes, the mother and the fetus. A strength in this study is the family-based design which can further refine the list of contributing rare variants. HSPA1L is a very plausible, and now well supported, risk modifier for preterm birth, but not one that we paid attention to before this work."


In your coverage please use this URL to provide access to the freely available article in PLOS Genetics:

Citation: Huusko JM, Karjalainen MK, Graham BE, Zhang G, Farrow EG, Miller NA, et al. (2018) Whole exome sequencing reveals HSPA1L as a genetic risk factor for spontaneous preterm birth. PLoS Genet 14(7): e1007394.

Funding: This work was supported by the Foundation for Pediatric Research, Finland, URL: (JMH); the University of California, San Francisco, California Preterm Birth Initiative (PTBi-CA), funded by Marc and Lynne Benioff, URL: (JMH); Orion Research Foundation, Finland, URL: (JMH); the Alma and K. A. Snellman Foundation, Oulu, Finland, URL: (JMH, MKK); Jane and Aatos Erkko Foundation, Finland, URL: (MH, MR); Sigrid Jusélius Foundation, Finland, URL: (MH); The Burroughs Wellcome Fund (BWF) Preterm Birth Initiative, URL: (GZ); March of Dimes Prematurity Research Center Ohio Collaborative, March of Dimes, URL: (21-FY13-19, KKR), the Fifth-Third Foundation, URL: (LJM), the Bill and Melinda Gates Foundation, URL: (OPP1113966, LJM and OPP52256, KKR and PB) and NIH/The Eunice Kennedy Shriver National Institute of Child Health and Human Development, URL: (HD091527, LJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The 23andMe authors are employees of and hold stock or stock options in 23andMe, Inc.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.